Virginia Tech®home

Institutional Biosafety Committee

Winter Submission Deadlines and IBCP Office Closure Information

Protocol application submission deadlines:
      Review at January 2023 IBC Meeting:   Submit by 12/13/2022
IBC Program Winter Office Closures:
      12/22/22 - 1/2/23:   The office will reopen on Tuesday, 1/3/23

IBCP Virginia Tech Campus Office Hours Information

The Institutional Biosafety Committee Program (IBCP) will hold office hours for all members of the Virginia Tech community.  During office hours, IBCP staff will be available to answer questions or to discuss your needs related to the use of biohazardous agents and the NIH Guidelines.  Below are the dates, times, and location information for upcoming office hours.  Information will be updated regularly, so please check this site for new dates.

To request IBCP office hours, discussions, or Zoom meetings for your personnel, during faculty meetings, classes, or seminars please contact the IBCP office (

Upcoming Office Hours       

December 6, 2022       ILSB, Room 1040         9 a.m. - 11:30 a.m.

About the Institutional Biosafety Committee

The Institutional Biosafety Committee (IBC) is administratively supported by the IBC Program staff.

Institutional Biosafety Committees (IBCs) are the cornerstone of institutional oversight of research that involves the use of biohazardous agents, including recombinant and/or synthetic nucleic acid molecules. The Virginia Tech IBC has been charged with the planning and implementation of the campus Biosafety Program with a purpose to ensure the health and safety of all personnel working with biohazardous agents.

The IBC functions to ensure that instructional and research activities conducted at Virginia Tech are in compliance with our federally mandated responsibilities and obligations, as outlined by current government requirements described in the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines); the Centers for Disease Control and Prevention (CDC) select agent guidelines and U.S. Department of Agriculture (USDA) select agent regulations, both associated with the National Select Agent Registry; and Occupational Health and Safety Administration (OSHA) regulations. Additional Select Agent guidance may be found at the National Institutes of Health (NIH) website. The Virginia Tech IBC consists of faculty, staff, and community representatives who have responsibility for reviewing all teaching and research activities involving:

  • Infectious agents (bacteria, viruses, prions, protozoans, fungi, etc.)
  • Biologically derived toxins
  • Human and/or non-human primate blood, body fluids, cells or tissue culture
  • Recombinant and/or Synthetic nucleic acid molecules
  • Genetic engineering and/or modification in any organism
  • Transgenic animals, invertebrates, and/or plants
  • Gene transfer
  • Select agents
  • Dual-use research of concern in Life Sciences
  • Synthetic biology

Experiments involving these activities cannot be started without prior protocol review and approval by the IBC.  The IBC drafts campus biosafety policies and procedures, and reviews individual research protocols for biosafety concerns. The IBC oversees and reviews research protocols involved in both teaching and research, regardless of the funding source(s). In areas of overlap, it coordinates with the IACUC when animals are used, the Institutional Review Board (IRB) when human subjects are involved, and the Radiation Safety Committee when applicable.